| Literature DB >> 30181910 |
Christophe Guédat1,2, Ursina Nagy1, Martin Schimmel1,3, Frauke Müller1,4, Murali Srinivasan1.
Abstract
The use of LOCATOR® attachments in implant-supported removable dental prostheses (ISRDPs) has been evidenced with conflicting clinical behavior in literature. This retrospective study aimed to investigate the long-term clinical performance of LOCATOR® attachments by evaluating the frequency of the encountered mechanical complication events (MCEs) and the factors that play a role in attachment wear (AW). The study recruited participants with ISRDPs on LOCATOR® attachments. Clinical parameters, number of MCEs (attachment replacements, attachment loosenings, denture cap-related events, loss of retention and/or insert, and implant fractures), and AW were recorded. Nonparametric tests were applied for statistical analyses (𝛼=0.05). Baseline demographics for the recruited 47 participants (mean age: 72.0 ± 9.0 years) revealed an implant survival rate of 94.9% (mean observation period: 54.8 months), average peri-implant probing depths, bleeding on probing scores, and plaque scores of 1.80 ± 1.50 mm, 0.70 ± 0.90, and 0.81 ± 0.90, respectively. MCEs were directly influenced by the time in use (p < 0.001). The most frequently encountered MCEs were loss of retention (p < 0.001) and denture cap-related complications (p = 0.004). AW was found to be significantly higher in the maxilla than in the mandible (p = 0.028); in the maxilla, the vestibular (p = 0.005) and mesial (p = 0.01) aspects were the most common wear sites. Maxillary implant overdentures revealed more vestibular AW (p = 0.013). In prostheses supported by >3 implants, vestibular (p = 0.046) and mesial (p = 0.032) AW were common. Lingual AW (p = 0.021) was observed more frequently when the support was <3 implants. Loss of retention and AW are the most common complications encountered with LOCATOR® attachments. Therefore, a modification in the attachment design along with an amelioration of the attachment surface may help decrease the maintenance needs and further enhance its clinical performance.Entities:
Keywords: LOCATOR® attachments; attachment wear; implant overdentures; mechanical complications; overdenture; removable dental prostheses
Year: 2018 PMID: 30181910 PMCID: PMC6115879 DOI: 10.1002/cre2.122
Source DB: PubMed Journal: Clin Exp Dent Res ISSN: 2057-4347
Figure 1Flow diagram of the entire participant identification, screening, and inclusion process (n: number; Ci/: maxillary implant‐supported complete removable dental prostheses [ISCRDPs]; /Ci: mandibular ISCRDPs; Ci/Ci: maxillary and mandibular ISCRDPs; Pi/: maxillary implant‐supported removable partial dental prostheses (ISRPDPs); /Pi: mandibular ISRPDPs)
Baseline demographics of the study cohort
| Groups | Number of participants | Age range (Mean ± | Number of implants placed (P), failed (F), survived (S), implant survival rate percentage (SR%), and mean (x) number of implants per participant | Time of implant failure | Follow‐up period in months (Mean ± | Implant plaque score (Mean ± | Implant bleeding score (Mean ± | Implant probing depth (Mean ± | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | W | T | P | F | S | SR% |
| E | D | L | ||||||
| Ci/‐ | 6 | 6 | 12 | 67.8 ± 8.6 | 50 | 4 | 46 | 92.0 | 4.2 | 2 | 1 | 1 | 58.2 ± 22.8 | 0.62 ± 0.80 | 0.40 ± 0.70 | 2.40 ± 1.70 |
| ‐/Ci | 14 | 13 | 27 | 74.4 ± 9.8 | 56 | 1 | 55 | 98.2 | 2.1 | 1 | 0 | 0 | 54.8 ± 22.8 | 1.07 ± 0.87 | 0.89 ± 1.00 | 1.40 ± 1.10 |
| Pi/‐ or ‐/Pi | 1 | 7 | 8 | 70.4 ± 8.1 | 12 | 1 | 11 | 91.7 | 1.5 | 1 | 0 | 0 | 49.5 ± 19.8 | 0.64 ± 0.83 | 0.66 ± 0.75 | 1.36 ± 1.50 |
| Total | 21 | 26 | 47 | 72.0 ± 9.5 | 118 | 6 | 112 | 94.9 | 2.5 | 4 | 1 | 1 | 54.8 ± 22.1 | 0.81 ± 0.90 | 0.70 ± 0.90 | 1.80 ± 1.50 |
|
| 0.131 | 0.191 | 0.479 |
|
|
| ||||||||||
Note. M: men; W: women; T: total; SD: standard deviation; SR%: survival rate percentage; E: early failure; D: delayed; L: late failures Ci/‐: maxillary implant‐supported complete removable dental prostheses (CRDPs); ‐/Ci: mandibular implant‐supported CRDPs; Pi/‐: maxillary implant‐supported removable partial dental prostheses (ISRPDPs); ‐/Pi: mandibular ISRPDPs.
Includes 4 implants that were replaced after implant failures.
Fisher's test.
Kruskal–Wallis test.
Mechanical complication events (MCEs) corrected for the time in use
| Time in use (years) | Number of participants surviving without any mechanical complication event (S), number of mechanical complication events (N), and number of patients (P) in subgroup experiencing at least one of those events | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap‐related event | Loss of retention | Loss of insert | Implant fracture | Any event | ||||||||
| S | N (P) | S | N (P) | S | N (P) | S | N (P) | S | N (P) | S | N (P) | S | N (P) | |
| 0–1 | 46 | 1 (1) | 47 | 0 (0) | 43 | 6 (4) | 31 | 19 (16) | 47 | 0 (0) | 47 | 0 (0) | 28 | 26 (19) |
| 1–2 | 46 | 0 (0) | 46 | 1 (1) | 43 | 0 (0) | 25 | 10 (10) | 46 | 1 (1) | 47 | 0 (0) | 22 | 12 (10) |
| 2–3 | 46 | 0 (0) | 46 | 0 (0) | 43 | 0 (0) | 20 | 16 (14) | 46 | 0 (0) | 47 | 0 (0) | 17 | 16 (14) |
| 3–4 | 46 | 0 (0) | 46 | 0 (0) | 43 | 0 (0) | 19 | 9 (8) | 46 | 0 (0) | 47 | 0 (0) | 16 | 9 (8) |
| 4–5 | 45 | 1 (1) | 46 | 0 (0) | 41 | 2 (2) | 15 | 13 (10) | 46 | 0 (0) | 47 | 0 (0) | 13 | 16 (10) |
| 5–6 | 45 | 0 (0) | 46 | 0 (0) | 41 | 0 (0) | 15 | 5 (4) | 46 | 0 (0) | 47 | 0 (0) | 13 | 5 (4) |
| 6–7 | 44 | 1 (1) | 46 | 0 (0) | 41 | 0 (0) | 15 | 3 (3) | 46 | 0 (0) | 46 | 1 (1) | 13 | 5 (3) |
| 7–8 | 44 | 0 (0) | 46 | 0 (0) | 41 | 0 (0) | 15 | 0 (0) | 46 | 0 (0) | 46 | 0 (0) | 13 | 0 (0) |
| Total | 3 (3) | 1 (1) | 8 (6) | 75 (32) | 1 (1) | 1 (1) | 89 (34) | |||||||
| Years until first event, (Mean ± | 3.5 ± 2.9 | 1.9 (NA) | 1.7 ± 2.0 | 1.6 ± 1.4 | 1.8 (NA) | 6.7 (NA) | 1.4 ± 1.3 | |||||||
| Events per patient, (Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.1 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | |||||||
|
| 1 | 1 |
|
| 1 | 1 |
| |||||||
Note. The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal regardless to the number of years in function: standard deviation.
Fisher's test.
Mechanical complication events (MCEs) corrected for type of prosthesis
| Groups | Number of participants ( | Number of sites (implants survived; | Follow‐up period in months (Mean ± | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap‐related event | Loss of retention | Loss of insert | Implant fracture | Any event | Mean events per patient ± | |||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | |||||
| Ci/‐ | 12 | 46 | 58.2 ± 22.8 | 0 | 0 (0.0) | 0 | 0 (0.0) | 4 | 2 (16.7) | 18 | 8 (66.7) | 0 | 0 (0.0) | 1 | 1 (8.3) | 23 | 9 (75.0) | 1.9 ± 1.7 |
| ‐/Ci | 27 | 55 | 54.8 ± 22.8 | 3 | 3 (11.1) | 0 | 0 (0.0) | 4 | 4 (14.8) | 47 | 18 (66.7) | 1 | 1 (3.7) | 0 | 0 (0.0) | 55 | 19 (70.4) | 2.0 ± 2.1 |
| Pi/‐ or ‐/Pi | 8 | 11 | 49.5 ± 19.8 | 0 | 0 (0.0) | 1 | 1 (12.5) | 0 | 0 (0.0) | 10 | 6 (75.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 11 | 6 (75.0) | 1.4 ± 1.6 |
| Total | 47 | 112 | 54.8 ± 22.1 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | |||||||||||
|
| 0.479 | 0.74 | 0.17 | 0.699 | 1 | 1 | 0.426 | 1 | ||||||||||
The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal across the type of ISRDP. The Kruskal–Wallis test compared the distribution of the follow‐up period between the groups.; Ci/: upper implant supported CRDP; /Ci: lower implant supported CRDP; Pi/: upper implant supported PRDP; /Pi: lower PRDP; SD: standard deviation; n: number.
Fisher's test.
Kruskal–Wallis test.
Mechanical complication events (MCEs) corrected for jaw rehabilitated
| Groups | Number of participants ( | Number of sites (implants survived; | Follow‐up period in months (Mean ± | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap‐related event | Loss of retention | Loss of insert | Implant Fracture | Any event | Mean events per patient ± | |||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | |||||
| Maxilla | 15 | 49 | 56.5 ± 22.2 | 0 | 0 (0.0) | 1 | 1 (6.7) | 4 | 2 (13.3) | 25 | 11 (73.3) | 0 | 0 (0.0) | 1 | 1 (6.7) | 31 | 12 (80.0) | 2.1 ± 1.7 |
| Mandible | 32 | 63 | 54.0 ± 22.3 | 3 | 3 (9.4) | 0 | 0 (0.0) | 4 | 4 (12.5) | 50 | 21 (65.6) | 1 | 1 (3.1) | 0 | 0 (0.0) | 58 | 22 (68.8) | 1.8 ± 2.0 |
| Total | 47 | 112 | 54.8 ± 22.1 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | |||||||||||
|
| 0.545 | 0.541 | 0.319 | 1 | 0.742 | 1 | 0.319 | 0.503 | ||||||||||
The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal across the type of jaw rehabilitated with the ISRDP. The Kruskal–Wallis test compared the distribution of the follow‐up period between the groups.; SD: standard deviation; n: number.
Fisher's test.
Kruskal–Wallis test.
Mechanical complication events (MCEs) corrected for implant number per patient
| Number of implant/s per prosthesis ( | Number of participants ( | Follow‐up period in months (Mean ± | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap‐related event | Loss of retention | Loss of insert | Implant Fracture | Any event | Mean events per patient ± | ||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | ||||
| 1 | 6 | 51.0 ± 16.0 | 0 | 0 (0.0) | 1 | 1 (16.7) | 0 | 0 (0.0) | 9 | 5 (83.3) | 0 | 0 (0.0) | 0 | 0 (0.0) | 10 | 5 (83.3) | 1.7 ± 1.8 |
| 2 | 30 | 55.0 ± 22.8 | 3 | 3 (10.0) | 0 | 0 (0.0) | 4 | 4 (13.3) | 52 | 21 (70.0) | 1 | 1 (3.3) | 0 | 0 (0.0) | 60 | 22 (73.3) | 2.0 ± 2.0 |
| 3 | 1 | 44.7 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0.0 (NA) |
| 4 | 7 | 50.9 ± 27.1 | 0 | 0 (0.0) | 0 | 0 (0.0) | 4 | 2 (28.6) | 9 | 4 (57.1) | 0 | 0 (0.0) | 1 | 1 (14.3) | 14 | 5 (71.4) | 2.0 ± 1.8 |
| 5 | 1 | 61.3 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 0.0 (NA) |
| 6 | 2 | 78.8 ± 7.5 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 5 | 2 (100.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 5 | 2 (100.0) | 2.5 ± 2.1 |
| Total | 47 | 54.8 ± 22.1 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | ||||||||||
|
| 0.478 | 1 | 0.213 | 0.665 | 0.322 | 1 | 0.362 | 0.358 | |||||||||
The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal across number of implants. The Kruskal–Wallis test compared the distribution of the follow‐up period between the groups.; SD: standard deviation; n: number.
Fisher's test.
Kruskal–Wallis test.
Mechanical complication events (MCEs) corrected for implant axial inclination
| Implant axial inclination in degrees | Number of participants ( | Number of sites (implants survived; | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap‐related event | Loss of retention | Loss of insert | Implant fracture | Any event | Mean events per patient ± | ||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | ||||
| 0–10 | 32 | 74 | 2 | 2 (6.3) | 0 | 0 (0.0) | 6 | 4 (12.5) | 46 | 22 (68.8) | 1 | 1 (3.1) | 1 | 1 (3.1) | 56 | 23 (71.9) | 1.8 ± 1.8 |
| 10–20 | 15 | 38 | 1 | 1 (6.7) | 1 | 1 (6.7) | 2 | 2 (13.3) | 29 | 10 (66.7) | 0 | 0 (0.0) | 0 | 0 (0.0) | 33 | 11 (73.3) | 2.2 ± 2.2 |
| Total | 47 | 112 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | ||||||||||
|
| 1 | 0.319 | 1 | 1 | 1 | 1 | 1 | ||||||||||
In this table, in order to be able to have exclusive patient groups, patients were grouped according to the highest inclination in their implants, thus reducing the analysis to the patient level. In addition to this, the events were not site‐specific. The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal regardless of the implant inclination.: standard deviation; n: number.
Fisher's test.
Mechanical complication events (MCEs) corrected for chewing efficiency
| Variance of Hue scores ranges | Number of participants ( | Number of sites (implants survived; n) | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap related event | Loss of retention | Loss of insert | Implant Fracture | Any event | Mean events per patient ± | ||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | ||||
| ≥0.501 | 1 | 2 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 1 | 1 (100.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 1 | 1 (100.0) | 1 (NA) |
| 0.401–0.500 | 10 | 21 | 0 | 0 (0.0) | 0 | 0 (0.0) | 1 | 1 (10.0) | 17 | 6 (60.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 18 | 6 (60.0) | 1.8 ± 2.6 |
| 0.301–0.400 | 15 | 39 | 2 | 2 (13.3) | 1 | 1 (6.7) | 5 | 3 (20.0) | 27 | 11 (73.3) | 1 | 1 (6.7) | 0 | 0 (0.0) | 36 | 12 (80.0) | 2.4 ± 1.9 |
| 0.201–0.300 | 16 | 32 | 1 | 1 (6.3) | 0 | 0 (0.0) | 2 | 2 (12.5) | 27 | 11 (68.8) | 0 | 0 (0.0) | 1 | 1 (6.3) | 31 | 12 (75.0) | 1.9 ± 1.7 |
| ≤0.100–0.200 | 5 | 18 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 3 | 3 (60.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 3 | 3 (60.0) | 0.6 ± 0.5 |
| Total | 47 | 112 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | ||||||||||
|
| 0.741 | 0.66 | 0.834 | 0.907 | 0.660 | 1.000 | 0.748 | ||||||||||
The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal across ranges of Hue scores.; SD: standard deviation; n: number.
Fisher's test.
Mechanical complication events (MCEs) corrected for wear
| Highest Wear (always highest value per site implant) | Number of participants ( | Number of sites (implants survived; | Number of mechanical complication events (N), number of patients (P) and share of patients (%) in subgroup experiencing at least one of those events | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Attachment replacement | Attachment loosening | Denture cap related event | Loss of retention | Loss of insert | Implant Fracture | Any event | Mean events per patient ± | ||||||||||
| N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | N | P (%) | ||||
| No wear | 33 | 65 | 3 | 3 (14.3) | 0 | 0 (0.0) | 3 | 3 (14.3) | 20 | 11 (52.4) | 1 | 1 (4.8) | 0 | 0 (0.0) | 27 | 12 (57.1) | 1.3 ± 1.7 |
| Minimal | 11 | 16 | 0 | 0 (0.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 14 | 4 (80.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 14 | 4 (80.0) | 2.8 ± 1.9 |
| Moderate | 20 | 36 | 0 | 0 (0.0) | 1 | 1 (6.3) | 4 | 2 (12.5) | 32 | 12 (75.0) | 0 | 0 (0.0) | 1 | 1 (6.3) | 38 | 13 (81.3) | 2.4 ± 2.2 |
| Advanced | 5 | 8 | 0 | 0 (0.0) | 0 | 0 (0.0) | 1 | 1 (20.0) | 9 | 5 (100.0) | 0 | 0 (0.0) | 0 | 0 (0.0) | 10 | 5 (100.0) | 2.0 ± 1.2 |
| Total | 69 | 125 | 3 | 3 (6.4) | 1 | 1 (2.1) | 8 | 6 (12.8) | 75 | 32 (68.1) | 1 | 1 (2.1) | 1 | 1 (2.1) | 89 | 34 (72.3) | 1.9 ± 1.9 |
| Mean ± | 0.1 ± 0.2 | 0.0 ± 0.1 | 0.2 ± 0.5 | 1.6 ± 1.6 | 0.0 ± 0.1 | 0.0 ± 0.1 | 1.9 ± 1.9 | ||||||||||
|
| 0.43 | 0.553 | 1 | 0.167 | 1 | 0.553 | 0.187 | ||||||||||
Wear could not be assessed in the two failed implants belonging to patient 18 (sites 25 and 21), and in one implant belonging to patient 36 (24). Each patient was attributed to one of the four wear groups according to their highest wear (of any type) across their implants. Since a single patient can have implants with several types of wear, the sum of number of participants is higher than the number of patients assessed in the study. The p value corresponds to a Fisher's test, with the null hypothesis being that the rate of patients experiencing each type of mechanical complication is equal across the groups. Minimal: visible scratches on the attachment; Moderate: TiN coating lost and grey metal visible; Advanced: severe wear damaging the shape of the attachments; SD: standard deviation; n: number.
Fisher's test.
Attachment wear corrected for prostheses type, jaw rehabilitated, and the number of implants per prostheses
| Groups | Number of participants ( | Number of sites (implants survived; | Follow‐up period in months (Mean ± | Number of patients (P) and share of patients (%) showing wear across the attachment split into four locations and overall (for any type of wear) per attachment. Mean wear (
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vestibular | Mesial | Distal | Lingual | Overall | |||||||||
| P (%) |
| P (%) |
| P (%) |
| P (%) |
| P (%) | |||||
| Type of prosthesis groups | Ci/‐ | 12 | 45 | 58.2 ± 22.8 | 10 (83.3) | 0.97 ± 0.71 | 8 (66.7) | 0.54 ± 0.57 | 4 (33.3) | 0.33 ± 0.50 | 2 (16.7) | 0.10 ± 0.23 | 7 (58.3) |
| ‐/Ci | 27 | 55 | 54.8 ± 22.8 | 9 (33.3) | 0.44 ± 0.75 | 8 (29.6) | 0.30 ± 0.52 | 6 (22.2) | 0.30 ± 0.64 | 4 (14.8) | 0.30 ± 0.76 | 8 (29.6) | |
| Pi/‐ or ‐/Pi | 8 | 11 | 49.5 ± 19.8 | 4 (50.0) | 0.88 ± 0.99 | 2 (25.0) | 0.50 ± 0.93 | 4 (50.0) | 1.13 ± 1.25 | 4 (50.0) | 1.13 ± 1.25 | 4 (50.0) | |
| Total | 47 | 111 | 54.8 ± 22.1 | 23 (48.9) | 0.65 ± 0.81 | 18 (38.3) | 0.39 ± 0.61 | 14 (29.8) | 0.45 ± 0.79 | 10 (21.3) | 0.39 ± 0.84 | 26 (55.3) | |
|
| 0.479 |
| 0.08 | 0.302 | 0.146 | 0.082 | |||||||
| Type of jaw rehabilitated | Maxilla | 15 | 48 | 56.5 ± 22.2 | 12 (80.0) | 1.04 ± 0.78 | 10 (66.7) | 0.70 ± 0.74 | 6 (40.0) | 0.53 ± 0.75 | 4 (26.7) | 0.34 ± 0.70 | 9 (60.0) |
| Mandible | 32 | 63 | 54.0 ± 22.3 | 11 (34.4) | 0.47 ± 0.76 | 8 (25.0) | 0.25 ± 0.49 | 8 (25.0) | 0.41 ± 0.82 | 6 (18.8) | 0.41 ± 0.90 | 10 (31.3) | |
| Total | 47 | 111 | 54.8 ± 22.1 | 23 (48.9) | 0.65 ± 0.81 | 18 (38.3) | 0.39 ± 0.61 | 14 (29.8) | 0.45 ± 0.79 | 10 (21.3) | 0.39 ± 0.84 | 26 (55.3) | |
|
| 0.545 |
|
| 0.324 | 0.704 |
| |||||||
| Number of implant/s per prosthesis ( | 1 | 6 | 51.0 ± 16.0 | 3 (50.0) | 1.00 ± 1.10 | 2 (33.3) | 0.67 ± 1.03 | 3 (50.0) | 1.00 ± 1.10 | 3 (50.0) | 1.00 ± 1.1 | 3 (50.0) | |
| 2 | 30 | 55.0 ± 22.8 | 11 (36.7) | 0.47 ± 0.73 | 8 (26.7) | 0.27 ± 0.50 | 7 (23.3) | 0.37 ± 0.79 | 5 (16.7) | 0.37 ± 0.88 | 10 (33.3) | ||
| 3 | 1 | 44.7 ± NA | 0 (0.0) | 0.00 ± NA | 0 (0.0) | 0.00 ± NA | 0 (0.0) | 0.00 ± NA | 0 (0.0) | 0.00 ± NA | 0 (0.0) | ||
| 4 | 7 | 50.9 ± 27.1 | 6 (85.7) | 1.00 ± 0.72 | 5 (71.4) | 0.58 ± 0.55 | 2 (28.6) | 0.33 ± 0.58 | 0 (0.0) | 0.00 ± 0.00 | 4 (57.1) | ||
| 5 | 1 | 61.3 ± NA | 1 (100.0) | 2.00 ± NA | 1 (100.0) | 1.60 ± NA | 1 (100.0) | 0.80 ± NA | 0 (0.0) | 0.00 ± NA | 1 (100) | ||
| 6 | 2 | 78.8 ± 7.5 | 2 (100.0) | 0.79 ± 0.65 | 2 (100.0) | 0.42 ± 0.12 | 1 (50.0) | 0.42 ± 0.59 | 2 (100.0) | 0.58 ± 0.12 | 1 (50.0) | ||
| Total | 47 | 54.8 ± 22.1 | 23 (48.9) | 0.65 ± 0.81 | 18 (38.3) | 0.39 ± 0.61 | 14 (29.8) | 0.45 ± 0.79 | 10 (21.3) | 0.39 ± 0.84 | 26 (55.3) | ||
|
| 0.478 |
|
| 0.366 |
| 0.167 | |||||||
The p value corresponds to a Fisher's test comparing the frequency of patients with wear among the different categories of patients, with the null hypothesis being that the share of patients with wear is equal across groups. The Kruskal–Wallis test compared the distribution of the follow‐up period between the groups. Ci/: upper implant‐supported CRDP; /Ci: lower implant‐supported CRDP; Pi/: upper implant‐supported PRDP; /Pi: lower PRDP p test; n: number; SD: standard deviation.
Fisher's test.
Kruskal–Wallis test.
Attachment wear corrected for the time in use and implant inclination
| Number of participants ( | Number of sites (implants survived) ( | Number of patients (P) and share of patients (%) showing wear across the attachment split into four locations and overall (for any type of wear) per attachment. Mean wear (
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vestibular | Mesial | Distal | Lingual | Overall | ||||||||
| P (%) |
| P (%) |
| P (%) |
| P (%) |
| P (%) | ||||
| Time in use per patient (years) | 1–2 | 6 | 15 | 1 (16.7) | 0.08 ± 0.20 | 1 (16.7) | 0.17 ± 0.41 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) |
| 2–3 | 3 | 6 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | |
| 3–4 | 6 | 12 | 2 (33.3) | 0.42 ± 0.80 | 0 (0.0) | 0.00 ± 0.00 | 1 (16.7) | 0.33 ± 0.82 | 1 (16.7) | 0.33 ± 0.82 | 1 (16.7) | |
| 4–5 | 8 | 16 | 3 (37.5) | 0.56 ± 0.82 | 2 (25.0) | 0.31 ± 0.70 | 1 (12.5) | 0.25 ± 0.71 | 1 (12.5) | 0.25 ± 0.71 | 3 (37.5) | |
| 5–6 | 15 | 37 | 9 (60.0) | 0.87 ± 0.86 | 9 (60.0) | 0.69 ± 0.71 | 6 (40.0) | 0.42 ± 0.61 | 3 (20.0) | 0.37 ± 0.77 | 9 (60.0) | |
| 6–7 | 5 | 13 | 5 (100.0) | 1.15 ± 0.55 | 3 (60.0) | 0.47 ± 0.62 | 3 (60.0) | 1.17 ± 1.25 | 2 (40.0) | 0.70 ± 1.30 | 4 (80.0) | |
| 7–8 | 3 | 10 | 3 (100.0) | 1.44 ± 1.08 | 3 (100.0) | 0.78 ± 0.63 | 3 (100.0) | 1.61 ± 0.84 | 3 (100.0) | 1.72 ± 1.18 | 2 (66.7) | |
| 8–9 | 1 | 2 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | |
| Total | 47 | 111 | 23 (48.9) | 0.65 ± 0.81 | 18 (38.3) | 0.39 ± 0.61 | 14 (29.8) | 0.45 ± 0.79 | 10 (21.3) | 0.39 ± 0.84 | 26 (55.3) | |
|
|
|
|
| 0.049 |
| |||||||
The p value corresponds to a Fisher's test comparing the frequency of patients/sites with wear among the different categories of patients/type of implant (according to site inclination) respectively, with the null hypothesis being that the share of patients/sites with wear is equal across groups. SD: standard deviation; n: number.
Fisher's test.
Attachment wear (AW) corrected for attachment height
| Attachment height (mm) | Number of participants with at least one implant with attachment height ( | Number of implants survived among those patients ( | Number of sites (S) and share of sites (%) showing wear across the attachment split into four locations and overall (for any type of wear) per attachment. Mean wear (
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vestibular | Mesial | Distal | Lingual | Overall | |||||||
| S (%) |
| S (%) |
| S (%) |
| S (%) |
| S (%) | |||
| 1 | 21 | 35 | 9 (25.7) | 0.46 ± 0.85 | 9 (25.7) | 0.46 ± 0.85 | 5 (14.3) | 0.46 ± 0.85 | 5 (14.3) | 0.46 ± 0.85 | 13 (37.1) |
| 2 | 24 | 34 | 12 (35.3) | 0.59 ± 0.86 | 5 (14.7) | 0.59 ± 0.86 | 8 (23.5) | 0.59 ± 0.86 | 7 (20.6) | 0.59 ± 0.86 | 17 (50.0) |
| 3 | 17 | 24 | 11 (45.8) | 0.79 ± 1.02 | 8 (33.3) | 0.79 ± 1.02 | 6 (25.0) | 0.79 ± 1.02 | 1 (4.2) | 0.79 ± 1.02 | 12 (50.0) |
| 4 | 8 | 14 | 8 (57.1) | 1.21 ± 1.12 | 7 (50.0) | 1.21 ± 1.12 | 2 (14.3) | 1.21 ± 1.12 | 2 (14.3) | 1.21 ± 1.12 | 11 (78.6) |
| 5 | 3 | 3 | 3 (100.0) | 2.00 ± 0.00 | 1 (33.3) | 2.00 ± 0.00 | 1 (33.3) | 2.00 ± 0.00 | 1 (33.3) | 2.00 ± 000 | 3 (100.0) |
| 6 | 1 | 1 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) | 0.00 ± 0.00 | 0 (0.0) |
| Total | 74 | 111 | 43 (38.7) | 0.70 ± 0.96 | 30 (27.0) | 0.43 ± 0.76 | 22 (19.8) | 0.41 ± 0.86 | 16 (14.4) | 0.31 ± 0.80 | 56 (50.5) |
| Number of worn implants per patient (Mean ± | 0.9 ± 1.2 | 0.6 ± 1 | 0.5 ± 0.8 | 0.3 ± 0.7 | 1.2 ± 1.3 | ||||||
|
| 0.050 | 0.151 | 0.719 | 0.399 | 0.041 | ||||||
The implant 24 belonging to patient 36 could not be evaluated for wear, bringing the total number of implants to 111 down from 112. The p‐value corresponds to a Fisher's test comparing the frequency of sites with wear among the different types of implants (according to attachment height), with the null hypothesis being that the share of sites with wear is equal across groups.; SD: standard deviation; n: number.
Fisher's test.
Attachment wear (AW) corrected for chewing efficiency
| Variance of Hue scores ranges | Number of participants ( | Number of sites (implants survived; | Number of patients (P) and share of patients (%) showing wear across the attachment split into four locations and overall (for any type of wear) per attachment. Mean wear (
| ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vestibular | Mesial | Distal | Lingual | Overall | |||||||
| P (%) |
| P (%) |
| P (%) |
| P (%) |
| P (%) | |||
| ≥0.501 | 1 | 2 | 0 (0.0) | 0.00 ± 0.00 | 1 (100.0) | 0.50 ± 0.00 | 1 (100.0) | 0.50 ± 0.00 | 1 (100.0) | 2.00 ± 0.00 | 1 (100.0) |
| 0.401–0.500 | 10 | 21 | 3 (30.0) | 0.28 ± 0.45 | 2 (20.0) | 0.18 ± 0.37 | 1 (10.0) | 0.30 ± 0.95 | 1 (10.0) | 0.30 ± 0.95 | 3 (30.0) |
| 0.301–0.400 | 15 | 39 | 9 (60.0) | 0.91 ± 1.00 | 9 (60.0) | 0.66 ± 0.70 | 6 (40.0) | 0.59 ± 0.84 | 3 (20.0) | 0.38 ± 0.90 | 6 (40.0) |
| 0.201–0.300 | 16 | 31 | 8 (50.0) | 0.63 ± 0.74 | 4 (25.0) | 0.27 ± 0.60 | 5 (31.3) | 0.49 ± 0.78 | 4 (25.0) | 0.44 ± 0.79 | 7 (43.8) |
| ≤0.100–0.200 | 5 | 18 | 3 (60.0) | 0.85 ± 0.86 | 2 (40.0) | 0.42 ± 0.69 | 1 (20.0) | 0.16 ± 0.36 | 1 (20.0) | 0.10 ± 0.22 | 2 (40.0) |
| Total | 47 | 111 | 23 (48.9) | 0.65 ± 0.80 | 18 (38.3) | 0.39 ± 0.61 | 14 (29.8) | 0.45 ± 0.79 | 10 (21.3) | 0.39 ± 0.84 | 26 (55.3) |
|
| 0.542 | 0.109 | 0.289 | 0.454 | 0.636 | ||||||
The p value corresponds to a Fisher's test comparing the frequency of patients with wear among the different categories of patients, with the null hypothesis being that the share of patients with wear is equal across groups.; SD: standard deviation; n: number.
Fisher's test.